AN2 Therapeutics (ANTX) Earnings Date & Reports

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

Industry: #Managed Health Care

Get AI intraday signals

A.I. Advisor

published Earnings

ANTX is expected to report earnings to fall 20.69% to -23 cents per share on August 06

AN2 Therapeutics ANTX Stock Earnings Reports

Q2'26

Est.

$-0.23

Q1'26

Missed

by $0.06

Q4'25

Missed

by $0.07

Q3'25

Est.

$-0.31

Q2'25

Beat

by $0.10

The last earnings report on May 11 showed earnings per share of -28 cents, missing the estimate of -23 cents. With 408.71K shares outstanding, the current market capitalization sits at 171.26M.

View a ticker or compare two or three

Compare

ANTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ANTX

A.I. Advisor